These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 7635771
1. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, Rawlings GA, Banerjee D, Pintilie M, Wilson GD. Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1319-29. PubMed ID: 7635771 [Abstract] [Full Text] [Related]
2. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1275-88. PubMed ID: 7635767 [Abstract] [Full Text] [Related]
3. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Tsang RW, Fyles AW, Li Y, Rajaraman MM, Chapman W, Pintilie M, Wong CS. Radiother Oncol; 1999 Jan 30; 50(1):85-92. PubMed ID: 10225561 [Abstract] [Full Text] [Related]
4. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P, Fortin A, Marandas P, Schwaab G, Wibault P, Malaise EP, Bobin S, Luboinski B, Eschwege F, Wilson G. Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):471-6. PubMed ID: 8655369 [Abstract] [Full Text] [Related]
5. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V. Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1165-72. PubMed ID: 8262843 [Abstract] [Full Text] [Related]
6. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy. Tsang RW, Juvet S, Pintilie M, Hill RP, Wong CS, Milosevic M, Chapman W, Levin W, Manchul LA, Fykes AW. Clin Cancer Res; 2003 Oct 01; 9(12):4387-95. PubMed ID: 14555510 [Abstract] [Full Text] [Related]
7. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794 [Abstract] [Full Text] [Related]
8. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy]. Corvò R, Giaretti W, Sanguineti G, Geido E, Bacigalupo A, Franzone P, Mereu P, Garaventa G, Barbieri M, Vitale V. Radiol Med; 1993 Jan 01; 86(1-2):135-42. PubMed ID: 8346344 [Abstract] [Full Text] [Related]
9. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Guenzi M, Margarino G, Bacigalupo A, Garaventa G, Barbieri M. J Clin Oncol; 1995 Aug 01; 13(8):1843-50. PubMed ID: 7636527 [Abstract] [Full Text] [Related]
10. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique. Tan LT, Jones B, Gee A, Kingston RE. Br J Radiol; 1997 Dec 01; 70(840):1259-69. PubMed ID: 9505845 [Abstract] [Full Text] [Related]
11. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. Tsang RW, Wong CS, Fyles AW, Levin W, Manchul LA, Milosevic M, Chapman W, Li YQ, Pintilie M. Radiother Oncol; 1999 Jan 01; 50(1):93-101. PubMed ID: 10225562 [Abstract] [Full Text] [Related]
12. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ. Radiother Oncol; 2003 Apr 01; 67(1):69-76. PubMed ID: 12758242 [Abstract] [Full Text] [Related]
13. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H. Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1309-17. PubMed ID: 7635770 [Abstract] [Full Text] [Related]
14. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Gasińska A, Urbański K, Jakubowicz J, Klimek M, Biesaga B, Wilson GD. Radiother Oncol; 1999 Jan 30; 50(1):77-84. PubMed ID: 10225560 [Abstract] [Full Text] [Related]
15. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Gasinska A, Fowler JF, Lind BK, Urbanski K. Acta Oncol; 2004 Jan 30; 43(7):657-66. PubMed ID: 15545186 [Abstract] [Full Text] [Related]
16. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Int J Radiat Oncol Biol Phys; 1998 May 01; 41(2):307-17. PubMed ID: 9607346 [Abstract] [Full Text] [Related]
17. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer. Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR. Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):966-71. PubMed ID: 22138462 [Abstract] [Full Text] [Related]
18. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Yeh SA, Wan Leung S, Wang CJ, Chen HC. Gynecol Oncol; 1999 Jan 01; 72(1):10-5. PubMed ID: 9889023 [Abstract] [Full Text] [Related]
19. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry. Benazzo M, Mevio E, Occhini A, Franchini G, Danova M. ORL J Otorhinolaryngol Relat Spec; 1995 Jan 01; 57(1):39-43. PubMed ID: 7700609 [Abstract] [Full Text] [Related]
20. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot? Haustermans K, Fowler J, Geboes K, Christiaens MR, Lerut A, van der Schueren E. Radiother Oncol; 1998 Feb 01; 46(2):157-67. PubMed ID: 9510043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]